July 3, 2018 / 6:28 AM / 5 months ago

Australia's Sirtex gets regulatory nod for Chinese buyout

July 3 (Reuters) - Sirtex Medical said on Tuesday Australia’s foreign investment regulator had approved its $1.4 billion buyout by a Chinese consortium.

The company had agreed last month to an offer from Beijing-based CDH Investments and its partner, China Grand Pharmaceutical and Healthcare Holdings, which trumped a bid from U.S.-based Varian Medical Systems. (Reporting by Ambar Warrick in Bengaluru; Editing by Gopakumar Warrier)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below